Evaxion Biotech
Kirsten Drejer is a highly respected name in pharma and biotech community. She is best known for being co-founder and CEO of Symphogen A/S. Prior to co-founding Symphogen in 2000, Kirsten held several scientific and managerial positions at Novo Nordisk A/S, including four years as Director of Diabetes Discovery, and three years as Corporate Facilitator. Kirsten is member of the board of directors of a number of biotech and pharma companies, including Zealand Pharma and Antag Therapeutics.
This person is not in the org chart
This person is not in any offices
Evaxion Biotech
7 followers
Evaxion is pioneering the field of immunoinformatics, working hard to bring novel, highly effective vaccines and antibodies to patients. By converting complex immunological data into computational algorithms, Evaxion is capable of programming the immune system to fight off a variety of diseases from cancers to hard-to-treat anti-microbial resistant infections.